Safe and effective canakinumab-treatment of neonatal onset multisystem inflammatory disease (NOMID)/ chronic infantile neurologic cutaneous and articular (CINCA)

Similar Items

• Chronic Infantile Neurological Cutaneous and Articular (CINCA) syndrome: a review
  od: Finetti, Martina, i dr.
  Izdano: (2016)
• Cytological vitreous findings in a patient with infantile neurological cutaneous and articular (CINCA) syndrome
  od: Adán, A, i dr.
  Izdano: (2007)
• Cytological vitreous findings in a patient with infantile neurological cutaneous and articular (CINCA) syndrome
  od: Adán, A, i dr.
  Izdano: (2009)
• Neonatal onset multisystem inflammatory disease (NOMID): Case report
  od: Urška Berden, i dr.
  Izdano: (2016-02-01)
• EXPERIENCE IN APPLICATION OF CANAKINUMAB IN PATIENTS WITH CRYOPYRIN-ASSOCIATED SYNDROME (SYNDROME CINCA/NOMID)
  od: T. V. Sleptsova, i dr.
  Izdano: (2014-05-01)